3 things to know about the future of biologics in spine surgery

Written by Rachel Popa | April 09, 2019 | Print  |

Spine surgery is shifting away from traditional devices and toward biologics, a material that attracts cells to increase bone formation in spinal fusion procedures, according to Jeffrey Wang, MD, who is the University of California-Los Angeles spine service chief and director of UCLA's spine surgery fellowship.

Dr. Wang shared the following thoughts on biologics with Spine-health, a peer-reviewed site for healthcare information:

1. Disc regeneration is the most exciting area for spine biologics, where surgeons use stem cells to repair or prevent injury to a disc.

2. Dr. Wang said factors preventing further or faster advancement in biologics include many surgeons , lacking the time, proper connections or interest in the field. Low research funding and complicated procedures also have impeded progress.

3. Dr. Wang said patients interested in the latest biologic treatments and burgeoning biologics companies will fuel a bigger role in spine surgery for biologics.

More articles on biologics:
Spinal fusion rates – 6 things to know about ALIF
New York attorney general sues stem cell clinic over unproven procedures — 8 insights
The cost-benefit of BMP for scoliosis surgery: 5 key findings

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months